Menu
Search
|

Menu

Close
X

Bio-Techne Corp TECH.OQ (NASDAQ Stock Exchange Global Select Market)

177.50 USD
-5.75 (-3.14%)
As of Oct 19
chart
Previous Close 183.25
Open 183.90
Volume 204,820
3m Avg Volume 88,628
Today’s High 183.90
Today’s Low 177.21
52 Week High 205.99
52 Week Low 121.89
Shares Outstanding (mil) 37.39
Market Capitalization (mil) 4,582.91
Forward P/E 60.42
Dividend (Yield %) 0.32 ( 1.04 )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
2.00 Mean rating from 9 analysts

KEY STATS

Revenue (mm, USD)
FY18
643
FY17
563
FY16
499
FY15
452
EPS (USD)
FY18
2.436
FY17
2.148
FY16
2.799
FY15
2.894
*Note: Units in Millions of U.S. Dollars
**Note: Units in U.S. Dollars

KEY RATIOS

Price to Earnings (TTM)
vs sector
60.42
33.64
Price to Sales (TTM)
vs sector
8.14
5.83
Price to Book (MRQ)
vs sector
4.82
4.89
Price to Cash Flow (TTM)
vs sector
33.67
22.92
Total Debt to Equity (MRQ)
vs sector
36.20
17.18
LT Debt to Equity (MRQ)
vs sector
36.20
12.76
Return on Investment (TTM)
vs sector
6.09
14.27
Return on Equity (TTM)
vs sector
8.32
15.99

EXECUTIVE LEADERSHIP

Robert Baumgartner
Independent Chairman of the Board, Since 2012
Salary: --
Bonus: --
Charles Kummeth
President, Chief Executive Officer, Director, Since 2014
Salary: $880,000.00
Bonus: $1,053,590.00
James Hippel
Chief Financial Officer, Senior Vice President, Since 2014
Salary: $460,000.00
Bonus: $356,310.00
Brenda Furlow
Senior Vice President, General Counsel, Secretary, Since 2014
Salary: --
Bonus: $67,120.00
David Eansor
Senior Vice President - Biotechnology, Since 2015
Salary: $430,000.00
Bonus: $256,210.00

COMPANY PROFILE

Sector: Healthcare
Industry: Biotechnology & Medical Research
Address:

614 McKinley Pl NE
MINNEAPOLIS   MN   55413-2610

Phone: +1612.3798854

Bio-Techne Corporation develops, manufactures and sells biotechnology reagents and instruments for the research and clinical diagnostic markets. The Company operates through three segments: Biotechnology, Clinical Controls and Protein Platforms. The Biotechnology segment develops, manufactures and sells biotechnology research and diagnostic products, such as cytokines, growth factors, immunoassays, antibodies and related reagents, across the world. The Clinical Controls segment develops and manufactures controls, calibrators, immunoassays and other reagents for the global clinical market. The Protein Platforms segment develops and commercializes systems and consumables for protein analysis. It markets immunoassays on different testing platforms, including microtiter-plate based kits sold under the trade name Quantikine, and immunoassays based on planar spotted surfaces and microfluidic-based multiplex immunoassays on automated testing platform.

SPONSORED STORIES